Cas:251575-93-6 6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one manufacturer & supplier

Chemical Name:6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one

CAS.NO:251575-93-6

Synonyms:6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one

Molecular Formula:C₃₃H₂₄O₃

Molecular Weight:468.54186

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one Use and application,6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one technical grade,usp/ep/jp grade.

Related News: The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one manufacturer Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. 6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one supplier Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. 6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one vendor The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one factory In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .